Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.

Levetiracetam

Popular

Description

There is on-going development of generic EU CTD Dossier of Levetiracetam, tablets, 250/500/750/1000 mg.

DCP slot confirmed.

Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

Levetiracetam (INN) is an anticonvulsant medication used to treat epilepsy. It is S-enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam.

Along with other anticonvulsants like gabapentin, it is also sometimes used to treat neuropathic pain.

Levetiracetam has recently been approved in the United Kingdom as a monotherapy treatment for epilepsy. It is also used in veterinary medicine for similar purposes.

Levetiracetam has potential benefits for other psychiatric and neurologic conditions such as Tourette syndrome, autism, and anxiety disorder, but its most serious adverse effects are behavioral and its benefit-risk ratio in these conditions is not well understood.

More details at: http://www.rxlist.com/keppra-drug.htm.

 

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 596

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

I’m a representative of Parafarm (Penza,...
614 Views
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
523 Views
Profitable and Modern Russian CMO with long...
496 Views
Adalimumab API available: - from EU cGMP...
10237 Views
Infliximab API available: - from EU cGMP...
516 Views
Normal 0 false false false EN-US X-NONE HE /*...
502 Views
Start-up pharmaceutical company from South...
1906 Views